Steven Cohen’s OptimizeRx OPRX Stock Holding History

Steven Cohen’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318K	Buy	+55,619	New	+$320K	﹤0.01%	3361
2026 Q1	–	Sell	-11,965	Closed	-$147K	–	4286
2025 Q4	$147K	Buy	+11,965	New	+$196K	﹤0.01%	3693
2024 Q1	–	Sell	-77,520	Closed	-$1.11M	–	2502
2023 Q4	$1.11M	Buy	+77,520	New	+$744K	﹤0.01%	1375
2023 Q3	–	Sell	-461,716	Closed	-$6.6M	–	2766
2023 Q2	$6.6M	Sell	461,716 -14,476	-3%	-$206K	0.02%	726
2023 Q1	$6.97M	Buy	+476,192	New	+$7.97M	0.02%	661
2022 Q1	–	Sell	-145,100	Closed	-$9.01M	–	1330
2021 Q4	$9.01M	Buy	+145,100	New	+$11M	0.04%	538

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Steven Cohen's OPRX Position: Q2 2026 in Review

Steven Cohen opened a new position in OptimizeRx (OPRX) in Q2 2026: 55,619 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #3361 among its holdings. This is a return to the name: Steven Cohen previously reported a position in OPRX as recently as Q4 2025.

Steven Cohen first reported a position in OPRX in Q4 2021 and has held it in 6 quarters since. The position peaked at $9.01M in Q4 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Steven Cohen held 55,619 shares of OptimizeRx worth $318K as of Q2 2026.
OptimizeRx was a new Steven Cohen position in Q2 2026.
OptimizeRx made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3361 holding.
Steven Cohen first reported a position in OptimizeRx in Q4 2021 and has held it in 6 quarters since.
Steven Cohen's OptimizeRx position peaked at $9.01M in Q4 2021.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.